04 September 2025
At Taiwan Expo USA 2025 in Dallas, the intelligent healthcare pavilion proudly highlighted Taiwan’s emerging power in digital health innovation. The pavilion, organized by the Taiwan External Trade Development Council (TAITRA) and International Trade Administration (TITA) the pavilion involved 10 growing organizations that have unveiled new ideas and changes in telemedicine, precision medicine, medical services, and artificial intelligence. The exhibition announced Taiwan’s dedication to ranking itself as a global partner in enhancing smart healthcare solutions.
The two key emerging medical centers securing their mark in Newsweek’s world’s best smart hospitals 2025 introduced new AI-driven diagnostic tools. The Taichung Veterans General Hospital (TCVGH) projected TAIMedImg PHDS, a patented ECG-oriented system holding the potential of forecasting pulmonary hypertension and screening, discarding the need for invasive tests. The platform is proven across numerous international hospitals and domestic medical centers. It is reshaping the next generation of non-invasive cardiovascular diagnostics.
Chang Gung Memorial Hospital, Linkou, has presented various engaging AI systems and models. Its digital pathology platform has accelerated diagnostic sensitivity by 96% gaining a green signal from the pathologists. They also involve ECG AI for forecasting left ventricle dysfunction and atrial fibrillation, essential for preventing strokes.
LiXel Inc. has described medical visualization with the help of air-touch technology and glasses-free 3D floating images, which are used in the conversion of anatomical structures. The system combines proprietary display with AI-fueled DICOM processing to support education, serve realistic 3D anatomy, telemedicine, and plan surgical procedures. Shennona Co., Ltd. is enhancing rehabilitation with its open-shoulder system, a platform merging AR software, an intelligent shoulder wheel, and a resistance band to help recovery from shoulder surgery and dysfunction. The pilot programs in Taiwan showed interest and attracted many patients and therapists. Further, the company is experiencing the best collaboration with health tech firms, insurers, and clinics to extend into home-based rehabilitation.
V5med Inc. has involved semiconductor imaging expertise in healthcare, initiating an AI platform that improves lung cancer screening through low-dose CT scans. Its model addresses COPD and lung fibrosis through integrating predictive functions, which the company looks at as the next frontier for AI in medicine. After successfully proving the model via cooperation in South Asia, V5med is moving towards the US market, leading to expansion and recognition.
04 September 2025
04 September 2025
04 September 2025
04 September 2025